NMD4C and MDC Host Second SMA Outcome Measure Training Workshop for Physiotherapists and Occupational Therapists Across Canada
The Spinal Muscular Atrophy (SMA) Motor Function Measures workshop organized by the NMD4C in collaboration with MDC took place in Montreal, Quebec on December 3rd, 2024 and was a resounding success. This workshop was established to harmonize assessment practices for the following SMA outcome measures across Canada:
- Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders
- Bayley’s Scale of Infant & Toddler Development
- Adapted Test of Neuromuscular Disorders
- Hammersmith Motor Functional Scale – Expanded
- Revised Upper Limb Module
- 6 Minute Walk Test
- Patient Reported Outcome Measures for SMA
The workshop complemented the interactive training session that took place earlier this year for French-speaking physiotherapists and occupational therapists in Quebec City. This initiative was created to deliver essential training to clinicians (physiotherapists and occupational therapists), ensuring a consistent approach to evaluating motor function in children and adults with SMA.
Content co-designed and co-developed by (L to R) Dr. Cam-Tu Émilie Nguyen, Sarah Turgeon-Desilets, Melissa Dermody, Angela Chiu, Cheryl Scholtes, Allison Banks & Dorothy Drost
Therapists from the following provinces were in attendance: Ontario, Quebec, Alberta, British Columbia, New Brunswick, Nova Scotia, Saskatchewan & Manitoba. Post-event surveys reinforced that the participants highly valued the opportunity to attend in-person training, to network with colleagues across Canada, engage in productive discussions on outcome measures for SMA and gain knowledge on establishing a clinic for the adult SMA population. The workshop also featured insights from a patient partner with lived experience – Catherine Boivin, who shared her experiences with the outcome measure assessments.
A report summarizing both the French and English workshops is currently in creation and will be available soon. The content from this SMA outcome measures workshop will be used to create an online interactive training resource to provide access to this cutting-edge training to a broader audience.
If you are interested in receiving training resources, or to learn more about our work on outcome measures, please contact NMD4C Outcome Measures and Natural History Coordinator Zainab Adamji to learn how we can work together.
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.